openPR Logo
Press release

Antibody Drug Conjugates Market Analysis by Technology, Application and Geography Leading with Lonza, Merck KGaA, Novasep, Pfizer, Piramal Group, Syngene

03-29-2019 06:04 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

Antibody Drug Conjugates (ADCs) are specifically to deliver cytotoxins to cancer cells with capacity to treat both solid tumors and hematologic cancers. With the help of a linker, an ADC is able to target and bind to cell-surface proteins found on cancer cells and release its cell-killing drugs. This property helps ADCs to selectively kill cancer cells and limit side effects for patients.

The Insight Partners adds ‘Antibody Drug ConjugatesMarket’ to its store, which furnishes a skillful and deep study of crucial business trends and upcoming Antibody Drug Conjugates market enhancement anticipations, key drivers and moderation, accounts of massive market competitors, categorization and foretell.

The antibody drug conjugates market is anticipated to grow in the forecast, owing to rising prevalence of cancer cases across the globe and growing geriatric population base. In addition, the presence of strong product offering in the pipeline by the players is expected to offer significant growth opportunities in the market during the forecast period.

Antibody Drug Conjugates Market to 2027 - Global Analysis and Forecasts By Technology (Cleavable Linker, Non-cleavable Linker); Application (Blood Cancer, Brain Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer) and Geography

Get Sample Copy of the Report at https://www.theinsightpartners.com/sample/TIPRE00003494

The "Global Antibody Drug Conjugates Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of antibody drug conjugates market with detailed market segmentation by technology, application and geography. The global antibody drug conjugates market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading antibody drug conjugates market players and offers key trends and opportunities in the market.

The reports cover key developments in the antibody drug conjugates market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from antibody drug conjugates market are anticipated to lucrative growth opportunities in the future with the rising demand for antibody drug conjugates market in the global market. Below mentioned is the list of few companies engaged in the antibody drug conjugates market.

The report also includes the profiles of key antibody drug conjugates market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

-AbbVie Inc.
-Baxter Healthcare Corporation
-CERBIOS - PHARMA SA
-F. Hoffmann-La Roche Ltd
-Lonza
-Merck KGaA
-Novasep
-Pfizer Inc.
-Piramal Group
-Syngene

Have Questions? Ask us at https://www.theinsightpartners.com/inquiry/TIPRE00003494

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibody Drug Conjugates Market - By Technology
1.3.2 Antibody Drug Conjugates Market - By Application
1.3.3 Antibody Drug Conjugates Market - By Region
1.3.3.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. ANTIBODY DRUG CONJUGATES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTIBODY DRUG CONJUGATES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTIBODY DRUG CONJUGATES MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBODY DRUG CONJUGATES - GLOBAL MARKET OVERVIEW
6.2. ANTIBODY DRUG CONJUGATES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00003494

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibody Drug Conjugates Market Analysis by Technology, Application and Geography Leading with Lonza, Merck KGaA, Novasep, Pfizer, Piramal Group, Syngene here

News-ID: 1677965 • Views: 395

More Releases from The Insight Partners

Polymer Foam Market Future Scenario, Growth rate, Market Segmentation, and Indus …
The report aims to provide an overview of the Polymer Foam Market with detailed market segmentation by type, end user industry, and geography. The global polymer foam market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading polymer foam market players and offers key trends and opportunities in the market. The report also includes the profiles of key
Automotive Logistics Market Opportunities and Key Manufacturers Report 2019-2027 …
Automotive Logistics Market accounted to US$ 203.0 Bn in 2018 and is expected to grow at a CAGR of 6.6% during the forecast period 2019 – 2027, to account to US$ 370.8 Bn by 2027. Worldwide Automotive Logistics Market Analysis to 2027 is a specialized and in-depth study of the Automotive Logistics Industry with a focus on the global market trend. The report aims to provide an overview of global Automotive
Algorithmic Trading Market Size 2019: by Manufacturers, Countries, Type and Appl …
Algorithmic Trading Market report is in-depth study on how the status is for the industry. This report includes a study of marketing and development strategies, along with the product portfolios of the leading companies. It also includes profiles of leading companies and brands that are driving the market with their recent developments, product launches, joint ventures, merges, and accusations. The algorithm trading market has experienced significant growth rate owing to increasing
Water Heater Market Demand, Supply, Growth Factors, Latest Rising Trend & Foreca …
Water Heater Market - Global Analysis to 2027 is an exclusive and in-depth study which provides a comprehensive view of the market includes the current trend and future amplitude of the market with respect to the products/services. The report provides an overview of the Water Heater Market with the detailed segmentation by components, end user, and region through in-depth traction analysis of the overall Water Heater industry. This report provides

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning